SUBSCRIBE
SUBSCRIBE

Opus Genetics

NEWS
Business
Spark Founders Launch Opus Genetics to Tackle Rare Forms of Blindness
The startup’s initial focus will be on rare blindness conditions affecting pediatric patients.
September 22, 2021
 · 
2 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Bio NC
Opus Genetics Leadership to Present at 3rd Annual Gene Therapy for Ophthalmic Disorders Conference
September 12, 2022
 · 
1 min read
Bio NC
Opus Genetics Hosts Inaugural Patient Advocacy Outreach Webinar on Inherited Retinal Diseases
September 1, 2022
 · 
2 min read
Business
Opus Genetics Expands its Leadership Team
July 21, 2022
 · 
5 min read
Bio NC
Opus Genetics to Present at OIS Retina Innovation Summit 2022
July 11, 2022
 · 
2 min read
Business
Opus Genetics Appoints Ben Yerxa, Ph.D., as Permanent Chief Executive Officer
June 21, 2022
 · 
3 min read
Business
Opus Genetics Appoints Jennifer Hunt Chief Development OfficerBiopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients
May 11, 2022
 · 
2 min read
Bio NC
Opus Genetics Announces Promising New Data Highlighting Potential of AAV-based Gene Therapies for the Treatment of Rare Inherited Retinal Diseases
May 4, 2022
 · 
3 min read
Business
Opus Genetics Appoints Brian Leising Vice President, Manufacturing
February 15, 2022
 · 
2 min read
Opus Genetics Announces Agreement with Massachusetts Eye and Ear and Harvard Medical School to License Third Program for Inherited Retinal Disease
November 11, 2021
 · 
2 min read
Bio NC
Opus Genetics Announces Presence at Eyecelerator@AAO 2021
November 8, 2021
 · 
2 min read
Load More